Literature DB >> 35701678

The expression and the tumor suppressor role of CLDN6 in colon cancer.

Huinan Qu1, Min Wang1, Miaomiao Wang1, Yuanyuan Liu1, Chengshi Quan2.   

Abstract

As a member of the tight junction family, CLDN6 is a tumor suppressor in breast cancer, but its role in colon cancer is unknown. In this research, we aimed at revealing the function of CLDN6 in colon cancer. We found that colon cancer tissues lowly expressed CLDN6, and the expression of CLDN6 was negatively correlated with lymph node metastasis. Similarly, CLDN6 was lowly expressed in the colon cancer cell line SW1116, and overexpression of CLDN6 inhibited cell proliferation in vitro and in vivo. Consistently, the migration and invasion abilities of cells were significantly inhibited after CLDN6 overexpression. In addition, we demonstrated that CLDN6 may inhibit the migration and invasion abilities by activating the TYK2/STAT3 pathway. Therefore, our data indicated that CLDN6 acted as a tumor suppressor and had the potential to be regarded as a biomarker for the progression of colon cancer.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CLDN6; Colon cancer; Invasion; Migration; Proliferation; TYK2/STAT3

Year:  2022        PMID: 35701678     DOI: 10.1007/s11010-022-04450-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  47 in total

1.  Tight junction protein claudin-6 inhibits growth and induces the apoptosis of cervical carcinoma cells in vitro and in vivo.

Authors:  Xiaowei Zhang; Yang Ruan; Yanru Li; Dongjing Lin; Chengshi Quan
Journal:  Med Oncol       Date:  2015-03-31       Impact factor: 3.064

Review 2.  Colorectal cancer.

Authors:  Evelien Dekker; Pieter J Tanis; Jasper L A Vleugels; Pashtoon M Kasi; Michael B Wallace
Journal:  Lancet       Date:  2019-10-19       Impact factor: 79.321

Review 3.  The role of claudins in cancer metastasis.

Authors:  S Tabariès; P M Siegel
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

Review 4.  Cancer treatment and survivorship statistics, 2014.

Authors:  Carol E DeSantis; Chun Chieh Lin; Angela B Mariotto; Rebecca L Siegel; Kevin D Stein; Joan L Kramer; Rick Alteri; Anthony S Robbins; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-06-01       Impact factor: 508.702

5.  CLDN1 induces autophagy to promote proliferation and metastasis of esophageal squamous carcinoma through AMPK/STAT1/ULK1 signaling.

Authors:  Jian Wu; FengXia Gao; Tao Xu; Jun Li; Zhi Hu; Chao Wang; Yang Long; XueMei He; Xin Deng; DeLian Ren; Biao Zhou; TianYang Dai
Journal:  J Cell Physiol       Date:  2019-09-09       Impact factor: 6.384

6.  Claudin-6 is down-regulated in gastric cancer and its potential pathway.

Authors:  You-Zhu Lu; Yang Li; Ting Zhang; Shu-Tang Han
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

7.  Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.

Authors:  Peiye Song; Yanru Li; Yuan Dong; Yingying Liang; Huinan Qu; Da Qi; Yan Lu; Xiangshu Jin; Yantong Guo; Yiyang Jia; Xinqi Wang; Wenhong Xu; Chengshi Quan
Journal:  J Exp Clin Cancer Res       Date:  2019-08-14

8.  Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance.

Authors:  Zachary R Visco; Gregory Sfakianos; Carole Grenier; Marie-Helene Boudreau; Sabrina Simpson; Isabel Rodriguez; Regina Whitaker; Derek Y Yao; Andrew Berchuck; Susan K Murphy; Zhiqing Huang
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

9.  Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma.

Authors:  Zhen Shen; Weiguo Song; Lili Qian; Jing Zhu; Yuebo Li; Min Li; Tianjiao Zhang; Weidong Zhao; Ying Zhou; Xingsheng Yang
Journal:  Oncol Rep       Date:  2020-12-08       Impact factor: 3.906

10.  Claudin-1 silencing increases sensitivity of liver cancer HepG2 cells to 5-fluorouracil by inhibiting autophagy.

Authors:  Hui Tong; Tao Li; Weihua Qiu; Zhecheng Zhu
Journal:  Oncol Lett       Date:  2019-10-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.